EYPT Eyepoint Pharmaceuticals Inc

EyePoint Pharmaceuticals Inc, formerly pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.

As of 07/23/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/27/2005
Outstanding shares:  28,741,475
Average volume:  169,209
Market cap:   $235,680,095
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    30233G209
ISIN:        US30233G2093
Sedol:      BMGS7L1
Valuation   (See tab for details)
PE ratio:   -5.32
PB ratio:   2.05
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy